ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

DeVita: It Was Time To Go, and The Action Is Hot At Memorial: Says He’ll Work Well With Paul Marks

August 19, 1988

Test Of HHS Secretary’s Remarks On cancer Mortality Rate Findings

November 22, 1996

Anil Potti Reprimanded by North Carolina Licensure Board

December 9, 2011

Guidelines Proposed For Control Grants

January 25, 1980

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

June 26, 1992

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007